Narrative Medicine in Metastatic Prostate Cancer Reveals Ways to Improve Patient Awareness & Quality of Care | Zendy

Giuseppe De Vincentis | Zendy; Fabio Monari | Zendy; Sergio Baldari | Zendy; Matteo Salgarello | Zendy; Viviana Frantellizzi | Zendy; Elisabetta Salvi | Zendy; Luigi Reale | Zendy; Silvia Napolitano | Zendy; Giario Conti | Zendy; Enrico Cortesi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Narrative Medicine in Metastatic Prostate Cancer Reveals Ways to Improve Patient Awareness & Quality of Care

Author(s) -

Giuseppe De Vincentis,

Fabio Monari,

Sergio Baldari,

Matteo Salgarello,

Viviana Frantellizzi,

Elisabetta Salvi,

Luigi Reale,

Silvia Napolitano,

Giario Conti,

Enrico Cortesi

Publication year - 2018

Publication title -

future oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.857

H-Index - 72

eISSN - 1744-8301

pISSN - 1479-6694

DOI - 10.2217/fon-2018-0318

Subject(s) - medicine , prostate cancer , denial , sadness , loneliness , disease , quality of life (healthcare) , cancer , narrative , radium 223 , oncology , family medicine , intensive care medicine , nursing , anger , psychiatry , psychotherapist , bone metastasis , psychology , linguistics , philosophy

Aim: To describe the journey of patients with metastatic castration-resistant prostate cancer (mCRPC) in treatment with radium-223. Methods: A multiperspective analysis was performed using narrative medicine in four Italian centers. Results: The substantial impact of mCRPC on quality of life through all phases of the disease was described. After an initial lack of awareness of the disease or denial of its effects, symptoms of pain, fatigue and side effects often led to sadness, fear and loneliness. The majority underwent radium-223 therapy positively, restoring their quality of life and routine activities. Conclusion: Using narrative medicine, the importance of a patient-centered approach in the pathway of care for patients with mCRPC through all the stages of the disease was highlighted.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research